Bristol-Myers Squibb Co (BMY)
55.31
+0.99
(+1.82%)
USD |
NYSE |
Nov 04, 12:59
Bristol-Myers Squibb Total Assets (Quarterly): 93.67B for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 93.67B |
| June 30, 2024 | 94.65B |
| March 31, 2024 | 99.03B |
| December 31, 2023 | 95.16B |
| September 30, 2023 | 91.26B |
| June 30, 2023 | 93.49B |
| March 31, 2023 | 94.28B |
| December 31, 2022 | 96.82B |
| September 30, 2022 | 98.20B |
| June 30, 2022 | 100.36B |
| March 31, 2022 | 103.03B |
| December 31, 2021 | 109.31B |
| September 30, 2021 | 110.89B |
| June 30, 2021 | 110.80B |
| March 31, 2021 | 112.44B |
| December 31, 2020 | 118.48B |
| September 30, 2020 | 125.54B |
| June 30, 2020 | 128.08B |
| March 31, 2020 | 129.28B |
| December 31, 2019 | 129.94B |
| September 30, 2019 | 57.43B |
| June 30, 2019 | 55.16B |
| March 31, 2019 | 34.83B |
| December 31, 2018 | 34.99B |
| September 30, 2018 | 33.73B |
| Date | Value |
|---|---|
| June 30, 2018 | 32.64B |
| March 31, 2018 | 33.08B |
| December 31, 2017 | 33.55B |
| September 30, 2017 | 33.98B |
| June 30, 2017 | 33.41B |
| March 31, 2017 | 32.94B |
| December 31, 2016 | 33.71B |
| September 30, 2016 | 33.73B |
| June 30, 2016 | 32.83B |
| March 31, 2016 | 31.89B |
| December 31, 2015 | 31.75B |
| September 30, 2015 | 31.78B |
| June 30, 2015 | 31.95B |
| March 31, 2015 | 33.58B |
| December 31, 2014 | 33.75B |
| September 30, 2014 | 33.45B |
| June 30, 2014 | 33.50B |
| March 31, 2014 | 33.42B |
| December 31, 2013 | 38.59B |
| September 30, 2013 | 36.80B |
| June 30, 2013 | 36.25B |
| March 31, 2013 | 35.96B |
| December 31, 2012 | 35.90B |
| September 30, 2012 | 36.04B |
| June 30, 2012 | 31.67B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
91.26B
Minimum
Sep 2023
129.94B
Maximum
Dec 2019
106.74B
Average
101.70B
Median
Total Assets (Quarterly) Benchmarks
| Amgen Inc | 90.88B |
| Johnson & Johnson | 178.29B |
| Eli Lilly and Co | 75.61B |
| Merck & Co Inc | 112.63B |
| Pfizer Inc | 216.19B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 76.47B |
| Shareholders Equity (Quarterly) | 17.14B |
| Debt to Equity Ratio | 2.902 |
| Current Ratio | 1.240 |
| Net Debt Paydown Yield | -2.30% |